CY1110242T1 - Αλας παραγωγου 7-ισοϊνδολινοκινολονοκαρβοξυλικου οξεος, μονενυδρη μορφη αυτου και συνθεση περιεχουσα τα ιδια ως δραστικο συστατικο - Google Patents

Αλας παραγωγου 7-ισοϊνδολινοκινολονοκαρβοξυλικου οξεος, μονενυδρη μορφη αυτου και συνθεση περιεχουσα τα ιδια ως δραστικο συστατικο

Info

Publication number
CY1110242T1
CY1110242T1 CY20101100540T CY101100540T CY1110242T1 CY 1110242 T1 CY1110242 T1 CY 1110242T1 CY 20101100540 T CY20101100540 T CY 20101100540T CY 101100540 T CY101100540 T CY 101100540T CY 1110242 T1 CY1110242 T1 CY 1110242T1
Authority
CY
Cyprus
Prior art keywords
monohydrain
isovinolinocinolocarcylic
salut
producer
acid
Prior art date
Application number
CY20101100540T
Other languages
English (en)
Inventor
Minoru Yamada
Shoichi Hamamoto
Kazuya Hayashi
Kazuko Takaoka
Hiroko Matsukura
Minako Yotsuji
Kenji Yonezawa
Katsuji Ojima
Tamotsu Takamatsu
Kyoko Taya
Hirohiko Yamamoto
Taro Kiyoto
Hironori Kotsubo
Original Assignee
Toyama Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27525611&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110242(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Toyama Chemical Co., Ltd. filed Critical Toyama Chemical Co., Ltd.
Publication of CY1110242T1 publication Critical patent/CY1110242T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η εφεύρεση σχετίζεται με μεθόδους παραγωγής ενός παραγώγου 7- ισοϊνδολινοκινοκαρβοξυλικού οξέος παρισταμένου από τον γενικό τύπο [1] το οποίο είναι χρήσιμο ως αντιβακτηριακό μέσο, και ενός ενδιάμεσου αυτού,
CY20101100540T 1997-10-27 2010-06-11 Αλας παραγωγου 7-ισοϊνδολινοκινολονοκαρβοξυλικου οξεος, μονενυδρη μορφη αυτου και συνθεση περιεχουσα τα ιδια ως δραστικο συστατικο CY1110242T1 (el)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP31137697 1997-10-27
JP9280798 1998-03-20
JP14058698 1998-05-07
JP24482898 1998-08-31
JP25365698 1998-09-08
EP98950405A EP1031569B1 (en) 1997-10-27 1998-10-27 Salt of a 7-isoindolinequinolonecarboxylic acid derivative, monohydrate thereof and composition containing the same as active ingredient

Publications (1)

Publication Number Publication Date
CY1110242T1 true CY1110242T1 (el) 2015-01-14

Family

ID=27525611

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100540T CY1110242T1 (el) 1997-10-27 2010-06-11 Αλας παραγωγου 7-ισοϊνδολινοκινολονοκαρβοξυλικου οξεος, μονενυδρη μορφη αυτου και συνθεση περιεχουσα τα ιδια ως δραστικο συστατικο

Country Status (19)

Country Link
US (4) US6337399B1 (el)
EP (1) EP1031569B1 (el)
KR (2) KR100611869B1 (el)
CN (3) CN1515555A (el)
AT (1) ATE461186T1 (el)
AU (1) AU750760B2 (el)
CA (3) CA2568251A1 (el)
CY (1) CY1110242T1 (el)
DE (1) DE69841563D1 (el)
DK (1) DK1031569T3 (el)
ES (1) ES2341509T3 (el)
HK (1) HK1030779A1 (el)
HU (1) HU229995B1 (el)
IL (2) IL135406A0 (el)
NO (2) NO318813B1 (el)
NZ (1) NZ504084A (el)
PT (1) PT1031569E (el)
TW (2) TWI242012B (el)
WO (1) WO1999021849A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60128797D1 (de) * 2000-03-07 2007-07-19 Ranbaxy Lab Ltd EINTOPFSYNTHESE VON 3-CYCLOPROPYLAMINO-2- 2,4-DIBROMO-3-(DIFLUOROMETHOXY)BENZOYLö-2-PROPENSÄURE ALKYLESTER ALS NÜTZLICHES ZWISCHENPRODUKT FÜR ANTIBAKTERIELLE QUINOLON-ARZNEISTOFFE
DE10111262A1 (de) * 2001-03-09 2002-09-12 Studiengesellschaft Kohle Mbh Verfahren zur Herstellung von Vinyl- Aryl- und Heteroarylessigsäuren und ihrer Devivate
US6777420B2 (en) 2001-06-15 2004-08-17 Microbiotix, Inc. Heterocyclic antibacterial compounds
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
AU2006316452B2 (en) * 2005-11-24 2013-01-10 Dompe' Farmaceutici S.P.A. (R)-arylalkylamino derivatives and pharmaceutical compositions containing them
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
CN101298418B (zh) * 2008-06-13 2010-12-15 江苏康鹏农化有限公司 3-氧代-3-(2,4-二卤代-3-二氟甲氧基苯基)丙酸乙酯的制备方法
JP5921826B2 (ja) * 2010-06-30 2016-05-24 富山化学工業株式会社 ５−ブロモ−２−（１−置換エチル）安息香酸エステルの新規製造法
EA030867B1 (ru) 2011-08-31 2018-10-31 Оцука Фармасьютикал Ко., Лтд. Производное хинолона
WO2013121439A2 (en) * 2012-02-15 2013-08-22 Glenmark Generics Limited Process for garenoxacin mesylate
CN105837555B (zh) * 2016-03-31 2019-01-25 南京华威医药科技集团有限公司 加雷沙星及其中间体制备方法
CN105777631B (zh) * 2016-04-18 2018-06-29 浙江中欣氟材股份有限公司 一种1-环丙基-4-氧代-7-溴-8-二氟甲氧基-1,4-二氢喹啉-3-羧酸乙酯的合成方法
CN105801482B (zh) * 2016-04-18 2018-06-22 浙江中欣氟材股份有限公司 一种1-环丙基-4-氧代-7-溴-8-二氟甲氧基-1,4-二氢喹啉-3-羧酸乙酯的制备方法
CN106957255B (zh) * 2017-03-28 2018-01-09 上海馨远医药科技有限公司 一种(R)‑N‑Boc‑5‑溴‑1‑甲基异吲哚啉及其制备方法和应用
CN112028816B (zh) * 2020-09-11 2022-10-14 江阴迈康升华医药科技有限公司 一种取代异吲哚啉的合成方法
CN114105790A (zh) * 2021-12-14 2022-03-01 无锡捷化医药科技有限公司 一种3-氨基-4,5-二溴苯甲酸甲酯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996005192A1 (fr) 1994-08-12 1996-02-22 Toyama Chemical Co., Ltd. Derive du nouvel acide quinolone- ou naphthyridonecarboxylique ou son sel
DE4431821A1 (de) * 1994-09-07 1996-03-14 Bayer Ag Verfahren zur Herstellung von N-Arylaminoacrylsäurederivaten und die Verwendung so hergestellter N-Arylaminoacrylsäurederivate zur Herstellung von 4-Chinolon-3-carbonsäurederivaten
CN100395244C (zh) * 1996-02-09 2008-06-18 富山化学工业株式会社 喹诺酮羧酸衍生物或它们的盐类
JP4252282B2 (ja) * 2001-11-06 2009-04-08 富山化学工業株式会社 ２−［（１ｒ）−１−メチル−２−トリチル−２，３−ジヒドロ−１ｈ−５−イソインドリル］−１，３，６，２−ジオキサアザボロカンの非溶媒和物およびその製造法

Also Published As

Publication number Publication date
CA2593381C (en) 2010-05-25
HK1030779A1 (en) 2001-05-18
WO1999021849A1 (fr) 1999-05-06
CN1296369C (zh) 2007-01-24
US7371868B2 (en) 2008-05-13
KR100565362B1 (ko) 2006-03-30
ATE461186T1 (de) 2010-04-15
CN1515555A (zh) 2004-07-28
KR20050055796A (ko) 2005-06-13
TW593308B (en) 2004-06-21
CA2593381A1 (en) 1999-05-06
US6337399B1 (en) 2002-01-08
CA2568251A1 (en) 1999-05-06
HUP0101766A3 (en) 2002-10-28
NO20042109L (no) 2000-06-07
KR20010031474A (ko) 2001-04-16
CN1195752C (zh) 2005-04-06
CN1616455A (zh) 2005-05-18
TW200420557A (en) 2004-10-16
DE69841563D1 (de) 2010-04-29
AU750760B2 (en) 2002-07-25
US20070225506A1 (en) 2007-09-27
AU9648698A (en) 1999-05-17
CA2307824C (en) 2008-02-19
EP1031569A4 (en) 2003-04-23
HUP0101766A2 (hu) 2001-12-28
NO318813B1 (no) 2005-05-09
ES2341509T3 (es) 2010-06-21
HU229995B1 (en) 2015-04-28
IL135406A (en) 2006-10-05
NZ504084A (en) 2003-02-28
CA2307824A1 (en) 1999-05-06
CN1278257A (zh) 2000-12-27
TWI242012B (en) 2005-10-21
PT1031569E (pt) 2010-05-10
NO20002125D0 (no) 2000-04-26
KR100611869B1 (ko) 2006-08-11
US20020049328A1 (en) 2002-04-25
IL135406A0 (en) 2001-05-20
US20050203301A1 (en) 2005-09-15
EP1031569A1 (en) 2000-08-30
EP1031569B1 (en) 2010-03-17
US6482835B2 (en) 2002-11-19
DK1031569T3 (da) 2010-05-10
NO20002125L (no) 2000-06-07

Similar Documents

Publication Publication Date Title
CY1110242T1 (el) Αλας παραγωγου 7-ισοϊνδολινοκινολονοκαρβοξυλικου οξεος, μονενυδρη μορφη αυτου και συνθεση περιεχουσα τα ιδια ως δραστικο συστατικο
NO932870D0 (no) Ny fremgangsmaate for fremstilling av 9-amino-6-demetyl-6-deoksyetracykliner
FI98460B (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
IL123293A0 (en) Piperidine derivatives their preparation and use
ES2077138T3 (es) Derivados de aminocumarano, su produccion y su uso.
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
ATE211732T1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
ES2044836T3 (es) Derivado de la piperidina, su utilizacion y compuesto farmaceutico que lo contiene.
CY1107491T1 (el) Ενωσεις αζωτουχου αρωματικου δακτυλιου
CY1106545T1 (el) Ετεροκυκλικες ενωσεις, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν
TR199800608A2 (en) Propanolamin t�revleri, bunlar�n �retim usul�.
PT749305E (pt) Processo para a producao de composicoes de avermectina/zeina
FR2757857B1 (fr) Diselenures et selenosulfures aromatiques, leur preparation et leurs utilisations, notamment therapeutiques
CY1106446T1 (el) 5-υποκατεστημενα -αλκυλαμινοπυραζολικα παραγωγα ως παρασιτοκτονα
ATE132139T1 (de) Diaminoethylen-verbindungen
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
IT1247974B (it) Derivati di piperidina, loro preparazione e uso
TR199900592T2 (xx) Kromanol t�revlerinin haz�rland��� i�lem ve ara ba�lar
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
NO180779C (no) Pyridinderivater, fremgangsmåte for deres fremstilling, anvendelse derav, sett omfattende slike, og utgangsforbindelse for fremgangsmåten
DE69222143T2 (de) Indanderivate
AU4609701A (en) Colouring agent for keratin containing fibres
CY1105040T1 (el) Συνεχης μεθοδος δια την παρασκευην παραγωγων σουλφανικης φρουκτοπυραζονης